|
Forest Laboratories is an American pharmaceutical company headquartered in New York City. The company's research and development spending has grown rapidly in recent years and, as of 2007, approached almost a billion U.S. dollars a year,〔(【引用サイトリンク】title=Forest Laboratories financial statements )〕 which put it on the list of the top 100 global corporations in R&D spending.〔(【引用サイトリンク】title=The 1250 Largest Companies Worldwide in R&D Spending )〕 Forest Laboratories is also known for licensing European pharmaceuticals for sale in the United States. The company also has offices in St. Louis, Cincinnati, Jersey City, Oakland, Dublin, Kent and Paris. ==Corporate history== In January 2014, Forest agreed to acquire Aptalis Pharma for $2.9 billion in order to gain access to treatments for gastrointestinal ailments and cystic fibrosis. In February 2014, Actavis announced it would acquire Forest Laboratories for around $25 billion. In April 2014, Forest announced it would acquire Furiex Pharmaceuticals Inc. for $1 billion in cash. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Forest Laboratories」の詳細全文を読む スポンサード リンク
|